Lista de obras - Joseph R Osborne - Dominio Público Uruguay

18F-fluorodeoxy-glucose positron emission tomography marks MYC-overexpressing human basal-like breast cancers

artículo científico publicado en 2011

99mTc-labeled small-molecule inhibitors of prostate-specific membrane antigen: pharmacokinetics and biodistribution studies in healthy subjects and patients with metastatic prostate cancer

artículo científico publicado en 2014

A Perspective of the Future of Nuclear Medicine Training and Certification

artículo científico publicado en 2016

A Phase I/II Study for Analytic Validation of 89Zr-J591 ImmunoPET as a Molecular Imaging Agent for Metastatic Prostate Cancer

artículo científico publicado en 2015

A Worrisome Interventricular Septum

scientific article published on 01 December 2011

A prospective pilot study of (89)Zr-J591/prostate specific membrane antigen positron emission tomography in men with localized prostate cancer undergoing radical prostatectomy

artículo científico publicado en 2013

ACR Practice Parameter for the Performance of Therapy With Unsealed Radiopharmaceutical Sources

artículo científico publicado en 2015

Altered biodistribution of radiopharmaceuticals: role of radiochemical/pharmaceutical purity, physiological, and pharmacologic factors

scientific article published on July 2010

Anatomic and functional imaging in the diagnosis of spine metastases and response assessment after spine radiosurgery

artículo científico publicado en 2017

Anti-prostate-specific membrane antigen-based radioimmunotherapy for prostate cancer

artículo científico publicado en 2010

Automated framework for digital radiation dose index reporting from CT dose reports

artículo científico publicado en 2011

Cholecystokinin-assisted hydrodissection of the gallbladder fossa during FDG PET/CT-guided liver ablation

artículo científico publicado en 2013

Comparison of 18F-FDG PET/CT for Systemic Staging of Newly Diagnosed Invasive Lobular Carcinoma Versus Invasive Ductal Carcinoma

artículo científico publicado en 2015

Disparities in castration-resistant prostate cancer trials

artículo científico publicado en 2015

Early magnetic resonance imaging biomarkers to predict local control after high dose stereotactic body radiotherapy for patients with sarcoma spine metastases

artículo científico publicado en 2015

FDG-Avid Intrathecal Inflammation Following Administration of Intrathecal Methotrexate

artículo científico publicado en 2016

Guest Editorial

artículo científico publicado en 2016

Individual Patient Data Analysis of Randomized Clinical Trials: Impact of Black Race on Castration-resistant Prostate Cancer Outcomes

artículo científico

Metabolic tumor volume and total lesion glycolysis on FDG-PET/CT can predict overall survival after (90)Y radioembolization of colorectal liver metastases: A comparison with SUVmax, SUVpeak, and RECIST 1.0.

artículo científico publicado en 2016

PSMA-targeted dendrimers: a patent evaluation (WO2012078534).

artículo científico publicado en 2013

PVT1 Exon 9: A Potential Biomarker of Aggressive Prostate Cancer?

artículo científico publicado en 2015

Pairwise comparison of 89Zr- and 124I-labeled cG250 based on positron emission tomography imaging and nonlinear immunokinetic modeling: in vivo carbonic anhydrase IX receptor binding and internalization in mouse xenografts of clear-cell renal [...]

artículo científico publicado en 2014

Pan-Cancer Analysis of Genomic Sequencing Among the Elderly

artículo científico publicado en 2017

Patterns of Lymph Node Failure after Dose-escalated Radiotherapy: Implications for Extended Pelvic Lymph Node Coverage

artículo científico publicado en 2016

Phase 1 study of radiosensitization using bortezomib in patients with relapsed non-Hodgkin lymphoma receiving radioimmunotherapy with 131I-tositumomab

artículo científico publicado en 2014

Phase II study of Lutetium-177-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 for metastatic castration-resistant prostate cancer

artículo científico publicado en 2013

Prostate-specific membrane antigen-based imaging

artículo científico publicado en 2012

Racial/Ethnic Disparities in Genomic Sequencing

artículo científico publicado en 2016

Radioembolization as a Salvage Therapy for Heavily Pretreated Patients With Colorectal Cancer Liver Metastases: Factors That Affect Outcomes

artículo científico publicado en 2015

Radium-223 outcomes after multiple lines of metastatic castration-resistant prostate cancer therapy in clinical practice: implication of pre-treatment spinal epidural disease.

artículo científico publicado en 2016

Review of salvage therapy for biochemically recurrent prostate cancer: the role of imaging and rationale for systemic salvage targeted anti-prostate-specific membrane antigen radioimmunotherapy

artículo científico publicado en 2012

Roundtable on the Future of Nuclear Medicine Training

artículo científico publicado en 2015

Stereotactic body radiotherapy for metastatic spinal sarcoma: a detailed patterns-of-failure study.

artículo científico publicado en 2016

Striatal dopamine type 2 receptor availability in anorexia nervosa

scientific article published on 26 July 2015

Targeted elimination of prostate cancer by genetically directed human T lymphocytes

artículo científico publicado en 2005

Targeting of radiolabeled J591 antibody to PSMA-expressing tumors: optimization of imaging and therapy based on non-linear compartmental modeling

artículo científico publicado en 2016

The Influence of Diabetes Mellitus and Metformin on Distant Metastases in Oropharyngeal Cancer: A Multicenter Study

artículo científico publicado en 2015

Utility of FDG-PET in clinical neuroendocrine prostate cancer

artículo científico publicado en 2014

miR-1207-3p Is a Novel Prognostic Biomarker of Prostate Cancer

artículo científico publicado en 2016

miR-1207-3p regulates the androgen receptor in prostate cancer via FNDC1/fibronectin

artículo científico publicado en 2016

⁸⁹Zr-huJ591 immuno-PET imaging in patients with advanced metastatic prostate cancer

artículo científico publicado en 2014

Lista de obras de Joseph R Osborne

18F-fluorodeoxy-glucose positron emission tomography marks MYC-overexpressing human basal-like breast cancers

99mTc-labeled small-molecule inhibitors of prostate-specific membrane antigen: pharmacokinetics and biodistribution studies in healthy subjects and patients with metastatic prostate cancer

A Perspective of the Future of Nuclear Medicine Training and Certification

A Phase I/II Study for Analytic Validation of 89Zr-J591 ImmunoPET as a Molecular Imaging Agent for Metastatic Prostate Cancer

A Worrisome Interventricular Septum

A prospective pilot study of (89)Zr-J591/prostate specific membrane antigen positron emission tomography in men with localized prostate cancer undergoing radical prostatectomy

ACR Practice Parameter for the Performance of Therapy With Unsealed Radiopharmaceutical Sources

Altered biodistribution of radiopharmaceuticals: role of radiochemical/pharmaceutical purity, physiological, and pharmacologic factors

Anatomic and functional imaging in the diagnosis of spine metastases and response assessment after spine radiosurgery

Anti-prostate-specific membrane antigen-based radioimmunotherapy for prostate cancer

Automated framework for digital radiation dose index reporting from CT dose reports

Cholecystokinin-assisted hydrodissection of the gallbladder fossa during FDG PET/CT-guided liver ablation

Comparison of 18F-FDG PET/CT for Systemic Staging of Newly Diagnosed Invasive Lobular Carcinoma Versus Invasive Ductal Carcinoma

Disparities in castration-resistant prostate cancer trials

Early magnetic resonance imaging biomarkers to predict local control after high dose stereotactic body radiotherapy for patients with sarcoma spine metastases

FDG-Avid Intrathecal Inflammation Following Administration of Intrathecal Methotrexate

Guest Editorial

Individual Patient Data Analysis of Randomized Clinical Trials: Impact of Black Race on Castration-resistant Prostate Cancer Outcomes

Metabolic tumor volume and total lesion glycolysis on FDG-PET/CT can predict overall survival after (90)Y radioembolization of colorectal liver metastases: A comparison with SUVmax, SUVpeak, and RECIST 1.0.

PSMA-targeted dendrimers: a patent evaluation (WO2012078534).

PVT1 Exon 9: A Potential Biomarker of Aggressive Prostate Cancer?

Pairwise comparison of 89Zr- and 124I-labeled cG250 based on positron emission tomography imaging and nonlinear immunokinetic modeling: in vivo carbonic anhydrase IX receptor binding and internalization in mouse xenografts of clear-cell renal [...]

Pan-Cancer Analysis of Genomic Sequencing Among the Elderly

Patterns of Lymph Node Failure after Dose-escalated Radiotherapy: Implications for Extended Pelvic Lymph Node Coverage

Phase 1 study of radiosensitization using bortezomib in patients with relapsed non-Hodgkin lymphoma receiving radioimmunotherapy with 131I-tositumomab

Phase II study of Lutetium-177-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 for metastatic castration-resistant prostate cancer

Prostate-specific membrane antigen-based imaging

Racial/Ethnic Disparities in Genomic Sequencing

Radioembolization as a Salvage Therapy for Heavily Pretreated Patients With Colorectal Cancer Liver Metastases: Factors That Affect Outcomes

Radium-223 outcomes after multiple lines of metastatic castration-resistant prostate cancer therapy in clinical practice: implication of pre-treatment spinal epidural disease.

Review of salvage therapy for biochemically recurrent prostate cancer: the role of imaging and rationale for systemic salvage targeted anti-prostate-specific membrane antigen radioimmunotherapy

Roundtable on the Future of Nuclear Medicine Training

Stereotactic body radiotherapy for metastatic spinal sarcoma: a detailed patterns-of-failure study.

Striatal dopamine type 2 receptor availability in anorexia nervosa

Targeted elimination of prostate cancer by genetically directed human T lymphocytes

Targeting of radiolabeled J591 antibody to PSMA-expressing tumors: optimization of imaging and therapy based on non-linear compartmental modeling

The Influence of Diabetes Mellitus and Metformin on Distant Metastases in Oropharyngeal Cancer: A Multicenter Study

Utility of FDG-PET in clinical neuroendocrine prostate cancer

miR-1207-3p Is a Novel Prognostic Biomarker of Prostate Cancer

miR-1207-3p regulates the androgen receptor in prostate cancer via FNDC1/fibronectin

⁸⁹Zr-huJ591 immuno-PET imaging in patients with advanced metastatic prostate cancer